Filing Details
- Accession Number:
- 0001203311-21-000099
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-22 17:32:43
- Reporting Period:
- 2021-12-20
- Accepted Time:
- 2021-12-22 17:32:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-12-20 | 1,227 | $149.85 | 667,945 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.